-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Xylem, Lowers Price Target to $156

Benzinga·02/11/2026 14:33:28
Listen to the news
Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and lowers the price target from $166 to $156.